|

Hydroxydaunomycin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Doxorubicin Hydrochloride, Hydroxydoxorubicin Hydrochloride

Pipeline

Phase 2: 1

Top Sponsors

  • Weill Medical College of Cornell University1

Indications

  • Richter Syndrome1
  • Chronic Lymphocytic Leukemia1
  • Cancer1

New York, New York1 trial

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

Mount Sinai- Icahn School of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.